Latest Period
n/a
Security Snapshot
Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) Institutional Ownership
CUSIP: 03835L306
13F Institutional Holders and Ownership History from Q1 2024 to Q1 2025
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.001 par value
- Symbol
- APVO on Nasdaq
- Shares outstanding
- 2,864,322
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value is tracked under CUSIP 03835L306.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 0 to 0 between Q4 2024 and Q1 2025.
- Reported value moved from $0 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Investment Quick Answers
What is CUSIP 03835L306?
CUSIP 03835L306 identifies APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03835L306:
Significant Owners of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| L1 Capital Global Opportunities Master Fund, Ltd. | 7.6% | +23% | +$39,294 | 421,000 | +110% | L1 Capital Global Opportunities Master Fund, Ltd. | 21 Apr 2025 | |
| BIGGER CAPITAL FUND L P | 10% | +62% | 285,000 | +42% | BIGGER CAPITAL FUND L P | 18 Jun 2025 |